Workflow
九州通:加速AI技术赋能,驱动医药全链条数字化转型

Core Insights - The company, Jiuzhoutong, held its Q3 2025 earnings presentation on November 4, showcasing advancements in digitalization and AI technology applications [1] Group 1: Financial Performance - In the first three quarters of 2025, the company's R&D investment reached 229 million yuan, with the number of R&D personnel increasing to 1,591 [1] Group 2: Technological Advancements - Jiuzhoutong has developed an AI intelligent system covering multiple business scenarios through independent R&D and partnerships with companies like Alibaba Cloud and Tencent Cloud [1] - The company has created several intelligent platforms, including AI+Smart Logistics, AI+Traditional Chinese and Western Medicine Diagnosis, and AI+Medical Devices [1] Group 3: Business Applications - The orthopedic Chang'e platform and Jiuyi AI-assisted diagnosis system have significantly improved efficiency in surgical instrument inventory and disease diagnosis by integrating AI technology [1] - The smart logistics system employs intelligent scheduling algorithms, enhancing the "goods-to-person" picking efficiency by 10% [1] - Jiuyi AI-assisted diagnosis platform and the internal office system "Zhi Jiugo" have integrated the DeepSeek model, while Alibaba's "Tongyi Lingma" is applied in the R&D system, effectively shortening development time and enhancing operational and decision-making efficiency [1]